Home » Newsletters » BioWorld Science

BioWorld Science

April 29, 2015

View Archived Issues

Roche reflects on key accomplishments of first quarter 2015

Double-armed oncolytic adenovirus LOAd-703 controls tumor progression

Novel thiazole-valine peptide selectively reverses ABCB1-mediated MDR

Novel c-Myc transgenic mice have potential as model for human cancer

Stealth BioTherapeutics to develop Ocuvia for inherited mitochondrial optic neuropathies

NEOMED collaborates with McGill University on PARG inhibitors for cancer

Liposomal agent CAL-02 neutralizes bacterial toxins

CC-1807: a synthetic host defense protein mimetic for Gram-negative infections

Recombinant human histidyl-tRNA synthetase named FDA orphan drug

Critical Outcome Technologies files IND for COTI-2 in gynecological cancers

BioMarin completes rolling NDA for drisapersen in Duchenne muscular dystrophy

FDA grants fast track designation to GZ/SAR-402671 for Fabry's disease

Phase III data for CAZ-104 presented at ECCMID

Galapagos's filgotinib meets primary endpoint in phase II trial in rheumatoid arthritis

Ofatumumab plus fludarabine and cyclophosphamide meets endpoint in phase III trial in CLL

Clinical development of the nucleoside NS5B inhibitor MIV-802 for HCV infection

Shenzhen Hepalink Pharmaceutical to license Chinese rights to Resverlogix's RVX-208

FDA grants orphan drug designation to Bio-Path's Liposomal Grb-2

Kadmon discloses ROCK 2 inhibitors

Millenium Pharmaceuticals patents ABCG2 inhibitors

Merck & Co. introduces FFAR1 agonists

Glenmark patents ROR-gamma modulators

Istituto Italiano di Tecnologia reports development of Rev-erb inhibitors

FDA gives Brilinta priority review for prevention of post-MI cardiovascular events

Fast track designation for Cerulean's camptothecin nanoparticles for mRCC

PTC Therapeutics advances BMI-1 program into the clinic

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...